What causes hiccups and how can you get rid of them?
We all get hiccups from time to time, and sometimes they just won't seem to go away.
Mar 28, 2023
0
57
Organic Chemicals: News and Research on Benzamides
MeSH tree: D02.241.223.100.100
Scientists discover a new way to prevent secondary breast cancer
Scientists have discovered why breast cancer cells that have spread to the lungs may "wake up" following years of sleep, forming incurable secondary tumors.
Mar 13, 2023
0
150
Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population
Researchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutations in blood samples from a large cohort of survivors of pediatric cancer, compared with age-matched controls.
Feb 8, 2023
0
39
Mosquitoes are not repelled by vitamins and other oral supplements you might take
A longstanding medical myth suggests that taking vitamin B1, also known as thiamine, can make your body repel mosquitoes.
Dec 8, 2022
1
40
Countering pharma's expensive gaming of the drug patent system
Biomedical innovation reached a new era during the COVID-19 pandemic as drug development went into overdrive. But the ways that brand companies license their patented drugs grant them market monopoly, preventing other entities ...
Dec 6, 2022
0
59
Mosquitoes are everywhere right now, including giant ones and those that make us sick. Here's what you need to know
Like all insects, mosquitoes thrive in warmer weather. But what they really need is water. La Niña rainfall and flooding are providing the perfect breeding ground for mosquitoes, with numbers exploding in recent weeks.
Nov 18, 2022
0
44
Are drug companies the villain? New study questions claims of 'evergreening'
For years, brand drug companies have been villainized for "evergreening" or manipulating the law to extend the period of exclusivity for drugs beyond their 20-year patent—a practice critics say unfairly prevents competition ...
Nov 3, 2022
0
47
First-ever licencing deal struck for cancer drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
Oct 20, 2022
0
29
High magnetic field reduces side effects caused by anti-cancer drug imatinib
Researchers led by Prof. Zhang Xin at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences (CAS) combined the 9.4 T static magnetic field (SMF) with a commonly used anti-cancer drug imatinib mesylate ...
Oct 14, 2022
0
40
Old drugs offer new ways of treating bowel cancer
Old medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland researchers has found.
Oct 12, 2022
0
31
